Key2Brain AB
559239-8746ActiveDeveloping proprietary technology for next-generation brain targeting therapeutics.
Biotechnology Companykey2brain.se
Yleiskatsaus
- 10–19
- Työntekijät
- 2.5–5milj SEK
- Liikevaihto
- 2020
- Perustettu
Kuvaus
Key2Brain is a Swedish biotechnology company focused on developing next-generation therapies designed to treat severe diseases affecting the brain. Their core offering is a groundbreaking proprietary technology platform engineered to facilitate efficient uptake and broad distribution of therapeutics...
Tunnisteet
B2BPharmaceuticalsTechnology